PHOTO
Sharjah: As part of its substantial efforts to provide community members with the best diagnostic and therapeutic services, the Ministry of Health and Prevention (MoHAP) has officially opened the Al-Qassimi Hospital’s Regenerative Medicine Center. The newly launched center is equipped with state-of-the-art medical gadgets and devices, as well as qualified and competent medical, technical, and nursing teams.
From the plasma and hyperbaric oxygen therapy to the SFV treatment, the ministry’s first of its kind center includes a unit equipped with smart bandages and Four-Dimensional (4D) Bioprinting for self-adipose tissue printing.
Regenerative medicine is the branch of medicine that develops methods to regrow, repair, or replace damaged or diseased cells, organs, or tissues.
Qualitative addition
His Excellency Dr. Youssif Al Serkal, Director-General of the Emirates Health Services Corporation, said: “The new Regenerative Medicine Center at Al-Qassimi Hospital is a qualitative addition to our outstanding medical edifices spread across the country. This is part of our ongoing plans to fulfill the health requirements of community members, as well as our strategy to expand our specialized clinics' network and equip them with world-class medical devices and competent cadres.”
“The Center is also a paradigm shift towards further development of the hospital’s services, thanks to the presence of a highly competent multidisciplinary team and the availability of all capability, resources, and technology infrastructure, in addition to international partnerships with long-established medical organizations to encourage scientific research,”
Competitiveness of health institutions
Commending the high competence of Al-Qassimi Hospital’s medical and technical staff and their success in performing rare and complicated surgeries, Al Serkal pointed to MoHAP’s launch of Dr. Invivo 4D Bioprinting technology which is thought to be a paradigm shift in the regenerative and biomedicine, as it has opened a new era in the treatment of diabetic wounds, chronic wounds, and burns, this reinforcing the trust in our medical cadres and uplifting our health institutions’ competitiveness.
Expanding services
Dr. Kalthoum Al Baloushi, Director of MoHAP’s Hospitals Administration, said the inauguration of the Regenerative Medicine Center is part of the ministry’s plans to elevate the number of its specialized centers and clinics and provide them with highly qualified medical and nursing staff, explaining that the regenerative medicine has a substantial role in the treatment of knee and nervous system diseases, burns, wounds, urinary tract, diabetic foot, and other specialties, in accordance with the latest international updates.
Various specialties
Dr. Saqr Al Mualla, Deputy Technical Director of Al Qasimi Hospital, Head of the Department of Plastic, Reconstructive, and Burns, highlighted the importance of opening the Regenerative Medicine Center which includes various specialties, such as Orthopedic, wound, plastic, and urinary tract, owing to the success of this kind of treatment in regrowing and stimulating damaged tissues through the extraction of cells from patients' own fats.
Al Mualla pointed out the Centre’s medical team has successfully developed a laser wound healing therapy which is a five-point laser technique as standard management for complex wounds, adding that new therapies and techniques will be introduced soon to accelerate patients’ recovery from wounds and burns, besides developing the skills of the medical team to meet patients’ needs and keep pace with the new developments in the regenerative medicine.
-Ends-
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
